bo feng
Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, China
Associate Editor
Molecular and Cellular Oncology
Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, China
Associate Editor
Molecular and Cellular Oncology
Zhejiang Cancer Hospital, University of Chinese Academy of Sciences
Hangzhou, China
Associate Editor
Gastrointestinal Cancers: Gastric and Esophageal Cancers
Uniformed Services University of the Health Sciences
Bethesda, United States
Associate Editor
Pharmacology of Anti-Cancer Drugs
Qinghai University Medical College
Xining, China
Associate Editor
Molecular and Cellular Oncology
Other
Padua, Italy
Associate Editor
Head and Neck Cancer
CBIOS, Universidade LusĂłfona Research Center for Biosciences & Health Technologies
Lisbon, Portugal
Associate Editor
Pharmacology of Anti-Cancer Drugs
Hematology Department, Amyloidosis and Myeloma Unit, Hospital Clinic de Barcelona.
Barcelona, Spain
Associate Editor
Cancer Immunity and Immunotherapy
Mutidisciplinary NET Group, Umbria Regional Cancer Network
Perugia, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
Corpallium Pty Ltd.
Adelaide, Australia
Associate Editor
Molecular and Cellular Oncology
University of California, San Diego
La Jolla, United States
Associate Editor
Molecular and Cellular Oncology
National Cancer Institute Foundation (IRCCS)
Milan, Italy
Associate Editor
Thoracic Oncology
Brown University
Providence, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Genoa
Genoa, Italy
Associate Editor
Hematologic Malignancies
Instituto OncoclĂnicas
Rio de Janeiro, Brazil
Associate Editor
Thoracic Oncology
University of Lisbon
Lisbon, Portugal
Associate Editor
Cancer Imaging and Image-directed Interventions
Academic Department Gyanaecology, Mauriziano Hospital
Torino, Italy
Associate Editor
Gynecological Oncology